Key Findings from the Phase 1 Trial The Phase 1 study was a randomized, placebo-controlled, double-blind trial designed to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of subcutaneous MET-097
Managing heart health and diabetes requires a collaborative effort between patients and healthcare professionals
All of the organs, the lean organs in the body, including the brain shrink and the consequence could be frailty and the downsides of that
Plus, you can stay strong by being active and eating well
Improved ultracentrifuge cells for high-speed sedimentation equilibrium studies with interference optics
Consider 4 sessions upfront to learn fundamentals, then train independently using the programs in this article